Cargando…
Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases
Mycobacterial heat shock protein 65 gene (Hsp65) has been widely used for classification of Mycobacterial species, and detection of Mycobacterial genes by molecular methods and has proven useful in identification of Mycobacterial infection in various clinical conditions. Circulating antibody against...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022545/ https://www.ncbi.nlm.nih.gov/pubmed/31881708 http://dx.doi.org/10.3390/microorganisms8010047 |
_version_ | 1783498040093442048 |
---|---|
author | Zhang, Peilin Minardi, Lawrence M. Kuenstner, John Todd Zhang, Sylvia T. Zekan, Steve M. Kruzelock, Rusty |
author_facet | Zhang, Peilin Minardi, Lawrence M. Kuenstner, John Todd Zhang, Sylvia T. Zekan, Steve M. Kruzelock, Rusty |
author_sort | Zhang, Peilin |
collection | PubMed |
description | Mycobacterial heat shock protein 65 gene (Hsp65) has been widely used for classification of Mycobacterial species, and detection of Mycobacterial genes by molecular methods and has proven useful in identification of Mycobacterial infection in various clinical conditions. Circulating antibody against Mycobacterial hsp65 has been found in many clinical diseases including autoimmune diseases (Crohn’s disease, lupus erythematosus, multiple sclerosis, diabetes, etc.), atherosclerosis and cancers. The prevalence of anti-Hsp65 antibody in the normal healthy population is unknown. We determined the blood levels of antibody against Mycobacterial hsp65 in the normal population represented by 288 blood donors of the American Red Cross and tested the blood of 109 patients with Crohn’s disease and 28 patients with Sjogren’s syndrome for comparison. The seroprevalence of anti-Hsp65 IgG in the normal population of Red Cross donors was 2.8% (8 of 288 positive). The Hsp65 antibody levels were significantly elevated in patients with Crohn’s disease and Sjogren’s syndrome. The prevalence of Hsp65 antibody in Crohn’s disease patients was 67.9% (74 of 109 patients), and 85.7% for Sjogren’s patients (24 of 28 patients). Our data indicate that anti-Hsp65 antibody is rare in the normal population, but frequent in chronic diseases. The presence of circulating Hsp65 antibody reflects an abnormal immune (adaptive) response to Mycobacterial exposure in patients with chronic diseases, thus differentiating the patients with chronic diseases from those clinical mimics. |
format | Online Article Text |
id | pubmed-7022545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70225452020-03-09 Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases Zhang, Peilin Minardi, Lawrence M. Kuenstner, John Todd Zhang, Sylvia T. Zekan, Steve M. Kruzelock, Rusty Microorganisms Article Mycobacterial heat shock protein 65 gene (Hsp65) has been widely used for classification of Mycobacterial species, and detection of Mycobacterial genes by molecular methods and has proven useful in identification of Mycobacterial infection in various clinical conditions. Circulating antibody against Mycobacterial hsp65 has been found in many clinical diseases including autoimmune diseases (Crohn’s disease, lupus erythematosus, multiple sclerosis, diabetes, etc.), atherosclerosis and cancers. The prevalence of anti-Hsp65 antibody in the normal healthy population is unknown. We determined the blood levels of antibody against Mycobacterial hsp65 in the normal population represented by 288 blood donors of the American Red Cross and tested the blood of 109 patients with Crohn’s disease and 28 patients with Sjogren’s syndrome for comparison. The seroprevalence of anti-Hsp65 IgG in the normal population of Red Cross donors was 2.8% (8 of 288 positive). The Hsp65 antibody levels were significantly elevated in patients with Crohn’s disease and Sjogren’s syndrome. The prevalence of Hsp65 antibody in Crohn’s disease patients was 67.9% (74 of 109 patients), and 85.7% for Sjogren’s patients (24 of 28 patients). Our data indicate that anti-Hsp65 antibody is rare in the normal population, but frequent in chronic diseases. The presence of circulating Hsp65 antibody reflects an abnormal immune (adaptive) response to Mycobacterial exposure in patients with chronic diseases, thus differentiating the patients with chronic diseases from those clinical mimics. MDPI 2019-12-25 /pmc/articles/PMC7022545/ /pubmed/31881708 http://dx.doi.org/10.3390/microorganisms8010047 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Peilin Minardi, Lawrence M. Kuenstner, John Todd Zhang, Sylvia T. Zekan, Steve M. Kruzelock, Rusty Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title | Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title_full | Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title_fullStr | Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title_full_unstemmed | Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title_short | Serological Testing for Mycobacterial Heat Shock Protein Hsp65 Antibody in Health and Diseases |
title_sort | serological testing for mycobacterial heat shock protein hsp65 antibody in health and diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022545/ https://www.ncbi.nlm.nih.gov/pubmed/31881708 http://dx.doi.org/10.3390/microorganisms8010047 |
work_keys_str_mv | AT zhangpeilin serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases AT minardilawrencem serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases AT kuenstnerjohntodd serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases AT zhangsylviat serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases AT zekanstevem serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases AT kruzelockrusty serologicaltestingformycobacterialheatshockproteinhsp65antibodyinhealthanddiseases |